CEDARS SINAI MEDICAL CENTER 3
3 · Prometheus Biosciences, Inc. · Filed Mar 11, 2021
Insider Transaction Report
Form 3
CEDARS SINAI MEDICAL CENTER
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (1,200,000 underlying)- 592,500
Common Stock
Series A Preferred Stock
→ Common Stock (100,000 underlying)Series C Preferred Stock
→ Common Stock (2,500,000 underlying)Series D-1 Preferred Stock
→ Common Stock (254,442 underlying)Series D-2 Preferred Stock
→ Common Stock (361,565 underlying)
Footnotes (5)
- [F1]Shares of Series A Preferred Stock are convertible at any time, at the holder's election, at a ratio of ten-for-one share of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A Preferred Stock will automatically convert at the ratio of ten-for-one share of the Issuer's common stock. The Series A Preferred Stock has no expiration date.
- [F2]Shares of Series B Preferred Stock are convertible at any time, at the holder's election, at a ratio of ten-for-one share of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series B Preferred Stock will automatically convert at the ratio of ten-for-one share of the Issuer's common stock. The Series B Preferred Stock has no expiration date.
- [F3]Shares of Series C Preferred Stock are convertible at any time, at the holder's election, at a ratio of ten-for-one share of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series C Preferred Stock will automatically convert at the ratio of ten-for-one share of the Issuer's common stock. The Series C Preferred Stock has no expiration date.
- [F4]Shares of Series D-1 Preferred Stock are convertible at any time, at the holder's election, at a ratio of ten-for-one share of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series D-1 Preferred Stock will automatically convert at the ratio of ten-for-one share of the Issuer's common stock. The Series D-1 Preferred Stock has no expiration date.
- [F5]Shares of Series D-2 Preferred Stock are convertible at any time, at the holder's election, at a ratio of ten-for-one share of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series D-2 Preferred Stock will automatically convert at the ratio of ten-for-one share of the Issuer's common stock. The Series D-2 Preferred Stock has no expiration date.